Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations
- 30 April 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 24 (2), 79-83
- https://doi.org/10.1016/j.jdiacomp.2009.01.004
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Dipeptidyl Peptidase-4 InhibitorsDiabetes Care, 2007
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesThe Lancet, 2006
- Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2006
- Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 DiabetesJAMA, 2006
- Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2005
- Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic PatientsDiabetes Care, 2003
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995
- Measurements of Glucose ControlDiabetes Care, 1987
- Mean Amplitude of Glycemic Excursions, a Measure of Diabetic InstabilityDiabetes, 1970